Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Sell

C

Surmodics, Inc. Common Stock (SRDX)

Surgical & Medical Instruments & Apparatus

https://www.surmodics.com

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

9924 W 74TH ST
EDEN PRAIRIE, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/04/1998

Market Cap

571,750,025

Shares Outstanding

14,230,000

Weighted SO

14,233,768

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

OSA --.--%

LIVN --.--%

ELMD --.--%

KIDS --.--%

NPCE --.--%

INGN --.--%

LUNG --.--%

APYX --.--%

NUVA --.--%

Beta

1.1760

Last Div

0.0000

Range

25.17-42.44

Chg

0.3550

Avg Vol

462627

Mkt Cap

571750025

Exch

NASDAQ

Country

US

Phone

952 500 7000

DCF Diff

36.7040

DCF

3.0160

Div Yield

0.0000

P/S

4.7322

EV Multiple

472.2781

P/FV

4.8065

Div Yield %

0.0000

P/E

-405.9062

PEG

-48.7042

Payout

0.0000

Current Ratio

3.9788

Quick Ratio

3.2160

Cash Ratio

1.2033

DSO

72.6792

DIO

109.1874

Op Cycle

181.8666

DPO

22.5817

CCC

159.2849

Gross Margin

0.5738

Op Margin

-0.0619

Pretax Margin

-0.0758

Net Margin

-0.0116

Eff Tax Rate

0.8472

ROA

-0.0079

ROE

-0.0116

ROCE

-0.0476

NI/EBT

0.1528

EBT/EBIT

1.2240

EBIT/Rev

-0.0619

Debt Ratio

0.1721

D/E

0.2585

LT Debt/Cap

0.1999

Total Debt/Cap

0.2054

Int Coverage

-4.1729

CF/Debt

-0.0707

Equity Multi

1.5017

Rec Turnover

5.0221

Pay Turnover

16.1635

Inv Turnover

3.3429

FA Turnover

4.2316

Asset Turnover

0.6810

OCF/Share

-0.1524

FCF/Share

-0.4134

Cash/Share

2.6941

OCF/Sales

-0.0179

FCF/OCF

2.7120

CF Coverage

-0.0707

ST Coverage

-2.1156

CapEx Coverage

-0.5841

Div&CapEx Cov

-0.5841

P/BV

4.8065

P/B

4.8065

P/S

4.7322

P/E

-405.9062

P/FCF

-97.6016

P/OCF

-262.8994

P/CF

-262.8994

PEG

-48.7042

P/S

4.7322

EV Multiple

472.2781

P/FV

4.8065

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 02, 05:30 Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research

Revenue Product Segmentation